@article{04fb762888054a639c06841b6d88ee30,
title = "Does Guideline-Directed Medical Therapy for Heart Failure Offer Benefits after LVAD Placement? - A Call for a Randomized Clinical Trial",
author = "Yancy, {Clyde W.} and Fonarow, {Gregg C.} and Hernandez, {Adrian F.}",
note = "Funding Information: Neurohormonal Blockade and Clinical Outcomes in Patients With Heart Failure Supported by Left Ventricular Assist Devices Funding Information: spousal employment with Abbott Laboratories. Dr Fonarow reported personal fees from Abbott, Amgen, Bayer, CHF Solutions, Janssen, Medtronic, Merck, Novartis; grants from the National Institutes of Health outside the submitted work; and serves as an associate editor for JAMA Cardiology. Dr Hernandez reported grants and personal fees from AstraZeneca, Merck, and Novartis; personal fees from Bayer and Boston Scientific; and grants from Verily outside the submitted work.",
year = "2020",
month = feb,
doi = "10.1001/jamacardio.2019.5019",
language = "English (US)",
volume = "5",
pages = "183",
journal = "JAMA Cardiology",
issn = "2380-6583",
publisher = "American Medical Association",
number = "2",
}